Chairman Kamoya of FPMAJ’s Committee on NHI Drug Pricing Expresses Concern Over Long-Listed Drugs

Yoshiaki Kamoya, Chairman of the FPMAJ's NHI Drug Price Study Committee The Federation of Pharmaceutical Manufacturers’ Associations of Japan’s (FPMAJ) NHI Drug Price Study Committee elected Yoshiaki Kamoya (executive officer, Shionogi & Co.) as its new chairman at a general...read more